Emma Davenport and Hilary Martin to lead research groups in the Human Genetics Programme
Emma Davenport and Hilary Martin to lead research groups in the Human Genetics Programme
The Wellcome Sanger Institute is delighted to announce that it will be welcoming two new members of Faculty in September and October 2018: Hilary Martin and Emma Davenport. Both researchers have strong experience in studying the contributions of genetic variation to disease, or deciding whether or not a drug will be effective. Their work will help to lay the foundations of understanding needed for precision medicine – where the most effective treatments for individuals can be determined by reading the sequence of their genomes.